National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1269 out of 2,175

Result pages: prev   1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278   next


VAERS ID: 1236646 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-05
Onset:2021-04-06
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2239 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Malaise, Sudden death, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-07
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Exertional dyspnea; Hypertension (HTA); Comments: HTA COVID-19
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESPFIZER INC2021414246

Write-up: Sudden death; malaise; vomiting; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA) manufacturer report number ES-AEMPS-819239. A 82-years-old male patient received bnt162b2 (COMIRNATY), intramuscular on 05Apr2021 (Batch/Lot Number: EW2239) as single dose for covid-19 immunisation. Medical history included covid-19 from Jan2021 to an unknown date, mild exertional dyspnoea, HTA for years (did not use the public system and there is no record in his history except for the administration of this vaccine). The patient''s concomitant medications were not reported. The patient experienced sudden death on 07Apr2021, malaise and vomiting on 06Apr2021. It is reported unexpected death on 07Apr2021 with no suspected diagnosis. He presented with non-specific symptoms such as malaise and vomiting the following day (06Apr2021), which a private doctor related to the vaccine dose of the previous day. It seems that days before the vaccination he presented mild exertional dyspnoea which was not studied, according to his family. According to his family, until yesterday he lived a normal independent life. Yesterday he was assessed by his usual private doctor. It seems that they related the symptoms to the recent vaccination. This morning he vomited on 2 occasions. Assessment at home at 09:45. On 07Apr2021, patient with clear signs of death. Lying supine in his bed. they report that the last time they saw him alive was at 5 am. At 7 am they found him on the sofa, lying on his right side (he had lividity in the right costal area) and then moved him to his bed. No signs of violence were observed, exits with no history or known immediate cause. The patient died on 07Apr2021. It was not reported if an autopsy was performed. The outcome of the event sudden death was fatal, outcome of the other events was unknown. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Sudden death


VAERS ID: 1239373 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood corticotrophin, Coma scale, Computerised tomogram, Epilepsy, Generalised tonic-clonic seizure, Heart rate increased, Hypercapnia, Hypoxia, Loss of consciousness, Magnetic resonance imaging, SARS-CoV-2 test, Tachycardia, Wheezing
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Angioedema (broad), Asthma/bronchospasm (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Convulsions (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Eosinophilic pneumonia (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (broad), Respiratory failure (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Dehydration (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-16
   Days after onset: 14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: LASILIX [FUROSEMIDE]; DIFFU K; XARELTO
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COPD (COPD under O2); Oxygen therapy; Pulmonary embolism; Tobacco user
Allergies:
Diagnostic Lab Data: Test Name: CRH; Result Unstructured Data: Test Result:unknown; Test Name: glasgow; Result Unstructured Data: Test Result:3; Comments: At the entrance; Test Name: CT scan; Result Unstructured Data: Test Result:nothing acute; Test Name: tachycardia; Result Unstructured Data: Test Result:160/min; Test Name: MRI; Result Unstructured Data: Test Result:nothing acute; Test Name: COVID test; Result Unstructured Data: Test Result:negative
CDC Split Type: FRPFIZER INC2021380416

Write-up: epileptic seizures; 2 tonic-clonic seizures; lost consciousness; hypoxia; hypercapnia with wheezing; hypercapnia with wheezing; tachycardia at 160/min; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number FR-AFSSAPS-MA20211071. An 80-year-old male patient received bnt162b2 (COMIRNATY), intramuscular on an unspecified date (Batch/Lot Number: Unknown) as SINGLE DOSE for COVID-19 immunization. Medical history included tobacco user, COPD ( Chronic obstructive pulmonary disease) under O2, pulmonary embolism in 2018. Concomitant medications included furosemide (LASILIX), potassium chloride (DIFFU K) and rivaroxaban (XARELTO)'' all taken for an unspecified indication, start and stop date were not reported. The patient presented with epileptic seizures following vaccination with COMIRNATY on 09Mar2021. Also, on 09Mar2021, the patient lost consciousness at home and the ambulance service observed 2 tonicoclonic seizures. The patient received RIVOTRIL and was taken to the emergency room. At the entrance, the patient had Glasgow at 3, CT (computed tomography) scan and MRI ( magnetic resonance imaging) nothing acute, the patient wakes up gradually. COVID test negative. Subsequently, the patient was transferred to intensive care for hypoxia, hypercapnia with wheezing and tachycardia at 160/min. No more information on CRH. The evolution will be unfavorable thereafter, with death on 16Mar2021. The patient died on 16Mar2021 due to epileptic seizures, tonic-clonic seizures, lost consciousness and hypoxia. It was not reported if an autopsy was performed. The outcome of the events hypercapnia with wheezing and tachycardia at 160/min was unknown. No follow-up attempts are possible, information on batch number cannot be obtained.; Reported Cause(s) of Death: epileptic seizures; tonic-clonic seizures; lost consciousness; hypoxia


VAERS ID: 1239465 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-01
Onset:2021-04-03
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-03
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: RIVAROXABAN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Dementia Alzheimer''s type; Hypertension arterial; Thromboembolism
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021409426

Write-up: Sudden death; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number FR-AFSSAPS-PO20211723. A 76-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in left arm on 01Apr2021 (Lot Number: ET7205) as 0.3 mL, single for covid-19 immunization. Patient with advanced Alzheimer''s dementia for which she lives in a protected living unit, arterial hypertension and thromboembolic disease. She has been treated with rivaroxaban for upper limb thrombosis for a few months and presented with symptomatic Covid-19 infection in December 2020. Concomitant medications included rivaroxaban taken for thrombosis. The patient previously took rivaroxaban for deep vein thrombosis. No fall, no discomfort, no bleeding, no headache or other neurological sign. No digestive disturbances, no febrile episode, no abnormal signs were reported. The patient experienced sudden death on 03Apr2021 05:00. No particular sign on external examination of the body, no externalized bleeding. It was not reported if an autopsy was performed. The outcome was fatal. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Sudden death


VAERS ID: 1239704 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-07
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ1688 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: SARS-CoV-2 test, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-01
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unsure if patient has had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative
CDC Split Type: GBPFIZER INC2021416276

Write-up: Clot blood; This is a spontaneous report from a contactable consumer received from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202104150730180020. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EJ1688) first dose, via an unspecified route of administration on 07Jan2021, as a single dose for covid-19 immunisation. The patient medical history was not reported. It was unsure if the patient has had symptoms associated with COVID-19 and the patient was not enrolled in a clinical trial. Concomitant medications were not reported. The patient experienced clot blood on an unspecified date. It was reported that the paramedics tried to save the patient''s life. The patient underwent lab tests and procedures, which included a negative COVID-19 virus test on an unspecified date. The patient had not tested positive for covid-19 since having the vaccine. The patient died on 01Mar2021. It was not reported if an autopsy was performed and the reported cause of death was blood clot. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: blood clot


VAERS ID: 1239867 (history)  
Form: Version 2.0  
Age: 92.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-09
Onset:2021-02-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 300042460 / 1 LA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Loss of consciousness, Vaccination complication
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ASPIRIN CARDIO; ATACAND; BELOC ZOK; FLUDEX [INDAPAMIDE]
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: No adverse event, Continue: [UNK], Comment: No significant Medical History
Allergies:
Diagnostic Lab Data:
CDC Split Type: CHMODERNATX, INC.MOD20210

Write-up: Lost consciousness; Did not feel well; This regulatory authority case was reported by a physician (subsequently medically confirmed) and describes the occurrence of LOSS OF CONSCIOUSNESS (Lost consciousness) and VACCINATION COMPLICATION (Did not feel well) in a 92-year-old male patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) (batch no. 300042460) for COVID-19 vaccination. The patient''s past medical history included No adverse event (No significant Medical History). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN CARDIO), CANDESARTAN CILEXETIL (ATACAND), METOPROLOL SUCCINATE (BELOC ZOK) and INDAPAMIDE (FLUDEX [INDAPAMIDE]) for an unknown indication. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced LOSS OF CONSCIOUSNESS (Lost consciousness) (seriousness criterion death) and VACCINATION COMPLICATION (Did not feel well) (seriousness criterion death). The patient died on 10-Feb-2021. The cause of death was not reported. It is unknown if an autopsy was performed. For mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Resuscitation attempted after the patient lost consciousness was ineffective and the patient died approximately 3 hours after not feeling well. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable. This is a 92 year-old, male patient who received mRNA-1273 Vaccine and experienced malaise and loss of consciousness with a fatal outcome, a day after receiving first dose of vaccine. No medical hx or conmeds were provided. The fatal outcome may be related to the patient''s pre-existing comorbidities Very limited information has been reported at this time. No further information is expected. Reporter did not allow further contact; Sender''s Comments: This is a 92 year-old, male patient who received mRNA-1273 Vaccine and experienced malaise and loss of consciousness with a fatal outcome, a day after receiving first dose of vaccine. No medical hx or conmeds were provided. The fatal outcome may be related to the patient''s pre-existing comorbidities Very limited information has been reported at this time. No further information is expected.; Reported Cause(s) of Death: unknown cause of death


VAERS ID: 1240077 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-06
Onset:2021-03-13
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2163 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral haemorrhage, Fall, Fibrin D dimer, Platelet count, Pulmonary embolism
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, venous (narrow), Accidents and injuries (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-07
   Days after onset: 24
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210314; Test Name: Fibrin D dimer; Result Unstructured Data: Test Result:$g20000 ng/ml; Test Date: 20210313; Test Name: Platelet count; Result Unstructured Data: Test Result:155 x10 9/l; Test Date: 20210319; Test Name: Platelet count; Result Unstructured Data: Test Result:120 x10 9/l; Test Date: 20210326; Test Name: Platelet count; Result Unstructured Data: Test Result:160 x10 9/l; Test Date: 20210329; Test Name: Platelet count; Result Unstructured Data: Test Result:235 x10 9/l
CDC Split Type: LUPFIZER INC2021414224

Write-up: cerebral haemorrhage caused by the fall; right upper lobe dorsal cruoric pulmonary embolism; fall caused by pulmonary embolism; This is a spontaneous report received from a contactable physician downloaded from the Regulatory Authority (RA). The regulatory authority report number is LU-ALMPS-202102221. A 91-years-old male patient received first dose of bnt162b2 (COMIRNATY), intramuscular on 06Mar2021 (Lot Number: EP2163) as 30 ug, single for covid-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient was with no medical history and no long term treatment at all. He lived autonomous at home. On 13MAr2021, he experienced right upper lobe dorsal cruoric pulmonary embolism leading to a fall. The patient was hospitalized. He received 2 doses of CLEXANE 40. The patient was diagnosed with cerebral haemorrhage close to admission, so CLEXANE was stopped and non anticoagulation was continued. On admission platelets were 155 G/L. It was stated that the fall had resulted in a cerebral haemorrhage. On 14Mar2021 : D-dimer $g 20000 ng/mL. On 19Mar2021 : lower value of platelets: 120 G/L. Then on 26Mar2021, Platelet count was 160 G/L, on 29Mar2021, platelets had increased to 235 G/L. The patient was hospitalized from 13Mar2021 to an unknown date. The patient experienced cerebral haemorrhage caused by the fall (death, hospitalization) on 13Mar2021 , right upper lobe dorsal cruoric pulmonary embolism (hospitalization, life threatening) on 13Mar2021 with outcome of not recovered , fall caused by pulmonary embolism (death, hospitalization) on 13Mar2021. On 07Apr2021, patient died. It was not reported if an autopsy was performed. comment: Further information asked about clinical evolution during hospital stay. Drug reaction for all reported events: Did reaction recur on readministration? NO. Assessment: Source, Method IMPUTABILITY METHOD. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: fall caused by pulmonary embolism; cerebral haemorrhage caused by the fall


VAERS ID: 1240078 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-21
Onset:2021-04-07
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-07
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: DIGOXIN; SPIRONOLACTONE; ATORVASTATIN; BUMETANIDE; APIXABAN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Cerebrovascular accident; Chronic heart failure; Diverticulosis; Osteoarthritis; Peripheral vascular disease; Senile amyloidosis
Allergies:
Diagnostic Lab Data:
CDC Split Type: MTPFIZER INC2021414230

Write-up: pulmonary embolism; This is a spontaneous report received from a contactable physician downloaded from the Medicine Agency (MA) -WEB. The regulatory authority report number is MT-ADM-15042021. A 92-years-old male patient received bnt162b2 (Pfizer vaccine), via an unspecified route of administration on 21Mar2021 (Batch/Lot Number: Unknown) as single dose for COVID-19 vaccination. Medical history included peripheral vascular disease, atrial fibrilation, cerebrovascular accident, chronic heart failure, senile amyloidosis, diverticulosis, osteoarthritis, all from an unknown date and unknown if ongoing. Concomitant medications included digoxin taken for atrial fibrillation; spironolactone taken for heart failure; atorvastatin taken for hypercholesterolaemia; bumetanide taken for heart failure; apixaban taken for atrial fibrillation. The patient experienced pulmonary embolism on 07Apr2021. Clinical course reported as follow: patient woke up in the morning and went to the bathroom and suffered a sudden death which was clinically highly suggestive of a dislodged thrombus resulting in massive/fatal pulmonary embolism. The suspect adverse drug reactions was fatal. The adverse drug reaction was not caused by a medication error. The patient died on 07Apr2021. It was not reported if an autopsy was performed. Sender''s Comments: Pulmonary embolism - unexpected, challenge: compatible, Re-challenge: RO, De-challenge: incocnlusive, Outcome C1. Sign and symptoms - compatible, lab test: L0. Alternate non-drug explanation; present. Outcome S1, outcome I1 uncertain. No follow-up attempts possible. Information on lot and batch numbers cannot be obtained.; Reported Cause(s) of Death: Pulmonary embolism


VAERS ID: 1240322 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-29
Onset:2021-03-30
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Laboratory test, SARS-CoV-2 test positive
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-30
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Hemodialysis
Allergies:
Diagnostic Lab Data: Test Date: 20210329; Test Result: Lab test; Inconclusive; Test Date: 20201019; Test Name: corona (SARS-CoV-2 test positive) (23.1); Test Result: Positive; Result Unstructured Data: positive for COVID
CDC Split Type: NLMODERNATX, INC.MOD20210

Write-up: This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021. This regulatory authority case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DEATH (Overlijden) in a 70-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. The patient''s past medical history included COVID-19 on 19-Oct-2020 and Hemodialysis. On 29-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. Death occurred on 30-Mar-2021 The patient died on 30-Mar-2021. The cause of death was not reported. It is unknown if an autopsy was performed. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Oct-2020, SARS-CoV-2 test positive: positive Positive. On 29-Mar-2021, Laboratory test: inconclusive (Inconclusive). For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided. Treatment information was not provided.; Sender''s Comments: Limited information regarding the event has been provided at this time and a causal relationship cannot be excluded; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1240323 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-26
Onset:2021-03-31
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3647 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LIXIANA; CARVEDILOL; LANOXIN; INSPRA; ENTRESTO; FUROSEMIDE
Current Illness: Atrial fibrillation (Family History: false); Cardiac failure (Family History: false)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021409116

Write-up: Death; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the regulatory authority, regulatory authority number NL-LRB-00502735. An 81-year-old male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 26Mar2021 (Lot Number: ET3647) as single dose for covid-19 immunization. Medical history included ongoing atrial fibrillation, ongoing cardiac failure, both Family History: false. Concomitant medication included edoxaban tosilate (LIXIANA, tablet, 15mg) taken for atrial fibrillation from 2019; carvedilol (tablet, 3,125mg) taken for cardiomyopathy, atrial fibrillation from 2019; digoxin (LANOXIN, tablet, 0.125mg) taken for atrial fibrillation from 2019; eplerenone (INSPRA, tablet 25mg) taken for cardiomyopathy from 2019; sacubitril valsartan sodium hydrate (ENTRESTO, 24/26mg) taken for cardiomyopathy from 2019; furosemide taken for an unspecified indication from 2019. Past drug therapy included covid-19 vaccine Pfizer injection fluid 0.3ml on 19Feb2021 for covid-19 immunisation. The patient experienced death on 31Mar2021. The patient died on 31Mar2021. It was not reported if an autopsy was performed. The outcome of death is fatal. No follow-up attempts possible. No further information expected; Reporter''s Comments: BioNTech/Pfizer vaccine (Comirnaty): Past drug therapy BioNTech/Pfizer vaccine (Comirnaty): yes Date: 19Feb2021 Death: Additional information ADR: died in his sleep Confounding factors : confounding factors: heart failure, atrial fibrillation COVID19: Previous COVID-19 infection: No; Reported Cause(s) of Death: death


VAERS ID: 1240324 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-30
Onset:2021-03-31
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3674 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac asthma, SARS-CoV-2 test
SMQs:, Cardiac failure (narrow), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: HALOPERIDOL; COLECALCIFEROL; LACTULOSE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19
Allergies:
Diagnostic Lab Data: Test Date: 20210112; Test Name: corona, confirmed with test; Test Result: Positive
CDC Split Type: NLPFIZER INC2021414334

Write-up: acute cardiac asthma; This is as spontaneous report received from a contactable physician downloaded from the regulatory authority-WEB. The regulatory authority report number is NL-LRB-00502974. A 93-years-old female patient received the second dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: ET3674) as single dose for covid-19 immunisation. Patient received the first dose on 04Mar2021. Medical history included covid-19 from 12Jan2021 to an unknown date. Concomitant medications included haloperidol; colecalciferol; lactulose. The patient experienced acute cardiac asthma (death, life threatening) on 31Mar2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 12Jan2021. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected; Reported Cause(s) of Death: Cardiac asthma


Result pages: prev   1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1269&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166